Your browser doesn't support javascript.
loading
Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Tang, Chloe Pek Sang; Lip, Gregory Y H; McCormack, Terry; Lyon, Alexander R; Hillmen, Peter; Iyengar, Sunil; Martinez-Calle, Nicolas; Parry-Jones, Nilima; Patten, Piers E M; Schuh, Anna; Walewska, Renata.
Afiliação
  • Tang CPS; Oxford University Hospitals NHS Trust, Oxford, UK.
  • Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
  • McCormack T; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Lyon AR; Hull York Medical School, Hull, UK.
  • Hillmen P; Royal Brompton NHS Trust, London, UK.
  • Iyengar S; Leeds Teaching Hospital NHS Trust, Leeds, UK.
  • Martinez-Calle N; Royal Marsden Hospital NHS Trust, Sutton, UK.
  • Parry-Jones N; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Patten PEM; Aneurin Bevan University Health Board, Abergavenny, UK.
  • Schuh A; Comprehensive Cancer Centre, Kings College London, London, UK.
  • Walewska R; Oxford University Hospitals NHS Trust, Oxford, UK.
Br J Haematol ; 196(1): 70-78, 2022 01.
Article em En | MEDLINE | ID: mdl-34498258

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Sistema Cardiovascular / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Sistema Cardiovascular / Inibidores de Proteínas Quinases / Tirosina Quinase da Agamaglobulinemia Idioma: En Ano de publicação: 2022 Tipo de documento: Article